A R Gillams1, T Kurzawinski, W R Lees. 1. Department of Medical Imaging, The Middlesex Hospital and University College London Medical School, Mortimer St., London W1T 3AA, England.
Abstract
OBJECTIVE: The management of pancreatic duct disruption is complex and depends on several factors including the cause, morphology, and degree of disruption. ERCP can show duct disruption in as many as 75% of patients but is invasive and cannot detect disruption beyond an obstruction. We studied the role of secretin MR cholangiopancreatography in patients with suspected pancreatic duct disruption. CONCLUSION: Secretin MR cholangiopancreatography is a safe, noninvasive test that can provide additional useful information about duct integrity and facilitate management.
OBJECTIVE: The management of pancreatic duct disruption is complex and depends on several factors including the cause, morphology, and degree of disruption. ERCP can show duct disruption in as many as 75% of patients but is invasive and cannot detect disruption beyond an obstruction. We studied the role of secretin MR cholangiopancreatography in patients with suspected pancreatic duct disruption. CONCLUSION:Secretin MR cholangiopancreatography is a safe, noninvasive test that can provide additional useful information about duct integrity and facilitate management.
Authors: Eric H Rosenfeld; Adam Vogel; Robert T Russell; Ilan Maizlin; Denise B Klinkner; Stephanie Polites; Barbara Gaines; Christine Leeper; Stallion Anthony; Megan Waddell; Shawn St Peter; David Juang; Rajan Thakkar; Joseph Drews; Brandon Behrens; Mubeen Jafri; Randall S Burd; Marianne Beaudin; Laurence Carmant; Richard A Falcone; Suzanne Moody; Bindi J Naik-Mathuria Journal: Pediatr Surg Int Date: 2018-08-03 Impact factor: 1.827